We lastly analyzed the clinical significance of the levels of PDIA6 and PDIA4 in breast cancer using the publicly available Clinical Proteomic Tumor Analysis Consortium (CPTAC, http://ualcan.path.uab.edu/cgi-bin/CPTAC) database. This evidence concerns the gene PDIA4 and neoplasm.